These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2304345)

  • 1. Intralesional cis-diamminedichloroplatinum and purified collagen treatment of human metastatic malignancies: a feasibility study.
    Krag DN; Théon AP; Schneider PD; Goodnight JE
    J Surg Oncol; 1990 Feb; 43(2):83-7. PubMed ID: 2304345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma.
    Oratz R; Hauschild A; Sebastian G; Schadendorf D; Castro D; Bröcker EB; Orenberg EK
    Melanoma Res; 2003 Feb; 13(1):59-66. PubMed ID: 12569286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study.
    Burris HA; Vogel CL; Castro D; Mishra L; Schwarz M; Spencer S; Oakes DD; Korey A; Orenberg EK
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):496-503. PubMed ID: 9560102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
    Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases.
    Radny P; Caroli UM; Bauer J; Paul T; Schlegel C; Eigentler TK; Weide B; Schwarz M; Garbe C
    Br J Cancer; 2003 Nov; 89(9):1620-6. PubMed ID: 14583759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
    Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
    J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice.
    Landrito JE; Yoshiga K; Sakurai K; Takada K
    Anticancer Res; 1994; 14(1A):113-8. PubMed ID: 8166436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intralesional versus ip administration of cisplatin on squamous cell carcinoma of mice.
    Nagase M; Nomura T; Nakajima T
    Cancer Treat Rep; 1987 Sep; 71(9):825-9. PubMed ID: 3621215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent irradiation and intratumoral chemotherapy with cisplatin: a pilot study in dogs with spontaneous tumors.
    Théon AP; Madewell BR; Ryu J; Castro J
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1027-34. PubMed ID: 8083071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Patency to Central Airways Occluded by Malignant Endobronchial Tumors Using Intratumoral Injection of Cisplatin.
    Mehta HJ; Begnaud A; Penley AM; Wynne J; Malhotra P; Fernandez-Bussy S; Cope J; Shuster JJ; Jantz MA
    Ann Am Thorac Soc; 2015 Sep; 12(9):1345-50. PubMed ID: 26072968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intracavitary cisplatin for the treatment of childhood solid tumors in the chest or abdominal cavity.
    Boyer MW; Moertel CL; Priest JR; Woods WG
    J Clin Oncol; 1995 Mar; 13(3):631-6. PubMed ID: 7884424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors.
    Campana LG; Testori A; Curatolo P; Quaglino P; Mocellin S; Framarini M; Borgognoni L; Ascierto PA; Mozzillo N; Guida M; Bucher S; Rotunno R; Marenco F; De Salvo GL; De Paoli A; Rossi CR; Bonadies A
    Eur J Surg Oncol; 2016 Dec; 42(12):1914-1923. PubMed ID: 27424789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
    Steffens TA; Bajorin DF; Chapman PB; Lovett DR; Cody-Johnson BV; Templeton MA; Heelan RT; Wong GY; Portlock CS; Oettgen HF
    Cancer; 1991 Sep; 68(6):1230-7. PubMed ID: 1873774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors.
    Duvillard C; Romanet P; Cosmidis A; Beaudouin N; Chauffert B
    Ann Otol Rhinol Laryngol; 2004 Mar; 113(3 Pt 1):229-33. PubMed ID: 15053208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus.
    Wadler S; Haynes H; Beitler JJ; Hu X; Fell S; Camacho M; Levine B; Wiernik PH
    Cancer; 1996 Jul; 78(1):30-4. PubMed ID: 8646722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients.
    Frustaci S; Barzan L; Tumolo S; Comoretto R; Quadu G; Galligioni E; Lorenzini M; Crivellari D; Caruso G; Piccinin G
    Cancer; 1986 Mar; 57(6):1118-23. PubMed ID: 3943035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC).
    van Harskamp G; Boven E; Vermorken JB; van Deutekom H; Stam J; Njo KH; Karim AB; Tierie AH; Golding RP; Pinedo HM
    Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1735-8. PubMed ID: 2822636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.